Norepinephrine as the Intrinsic Contributor to Contact Lens–Induced Pseudomonas aeruginosa Keratitis
Investigative Opthalmology & Visual Science · 2023
DOI: 10.1167/iovs.64.5.26 ↗At a glance
Journal article in Investigative Opthalmology & Visual Science, 2023. Written by Bi Ning Zhang and 11 co-authors. Institution: Eye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China. Major MEDLINE topics: Keratitis, Contact Lenses, Pseudomonas Infections. Cited 5 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
Contact lens wear (CLW) is one of the leading risk factors for Pseudomonas aeruginosa keratitis (PAK). However, the intrinsic factors that contribute to the high susceptibility to keratitis during CLW remain to be elucidated. CLW over an extended period can elevate corneal norepinephrine (NE) concentration. In this study, we investigated the role of NE in promoting PAK.
Methods
We constructed an injury-induced PAK model and a CLW-induced PAK model to confirm the impact of NE during corneal infection. Pharmacological blockage of NE and gene knockdown mouse were used to investigate the downstream effector of NE. RNA sequencing was performed to explore the cellular alterations during NE treatment. Non-parametric Mann-Whitney U test or Kruskal-Wallis test were used to ascertain the significance (P < 0.05).
Results
Supplementation of NE led to PAK even without artificial corneal injury during CLW. The effect was mediated by the β2-adrenergic receptor (β2-AR) in the corneal epithelium. The β2-AR blockage by the NE antagonist ICI118,551 (ICI) or by deleting of its encoding gene Adrb2 significantly alleviated infection during CLW. Conversely, β2-AR activation compromised the integrity of the epithelium and significantly increased the cortical plaque marker ezrin. Transcriptome analysis identified that the protective effect of ICI on the keratitis was mediated by dual-specificity phosphatases. Suramin, a Dusp5 antagonist, abrogated the protective effect of ICI.
Conclusions
These data reveal a new mechanism by which NE acts as an intrinsic factor that promotes CLW-induced PAK and provide novel therapeutic targets for treating keratitis by targeting NE-β2-AR.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Eye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China.
- State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Qingdao, China.
- School of Ophthalmology, Shandong First Medical University, Qingdao, China.
- Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China.
- Eye Institute of Shandong First Medical University, Eye Hospital of Shandong First Medical University (Shandong Eye Hospital), Jinan, China.
- Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, China.
Cite
APA
Zhang, B. N., Qi, B., Chu, W. K., Song, F., Li, S., Dong, Q., Shao, Z., Zhang, B., Du, X., Ma, X., Jhanji, V., & Zhou, Q. (2023). Norepinephrine as the Intrinsic Contributor to Contact Lens–Induced Pseudomonas aeruginosa Keratitis. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.64.5.26
Vancouver
Zhang BN, Qi B, Chu WK, Song F, Li S, Dong Q, et al. Norepinephrine as the Intrinsic Contributor to Contact Lens–Induced Pseudomonas aeruginosa Keratitis. Investigative Opthalmology & Visual Science. 2023. doi:10.1167/iovs.64.5.26
BibTeX
@article{Zhang2023,
author = {Zhang, Bi Ning and Qi, Benxiang and Chu, Wai Kit and Song, Fangying and Li, Suxia and Dong, Qiaoqiao and Shao, Zheng and Zhang, Bin and Du, Xianli and Ma, Xiubin and Jhanji, Vishal and Zhou, Qingjun},
title = {Norepinephrine as the Intrinsic Contributor to Contact Lens–Induced Pseudomonas aeruginosa Keratitis},
journal = {Investigative Opthalmology & Visual Science},
year = {2023},
doi = {10.1167/iovs.64.5.26}
}
EUVIMED